-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Iterum Therapeutics plc quarterly/annual Depreciation history and growth rate from 2016 to 2023.
- Iterum Therapeutics plc Depreciation for the quarter ending March 31, 2024 was $7K, unchanged year-over-year.
- Iterum Therapeutics plc annual Depreciation for 2023 was $31K, a 63.1% decline from 2022.
- Iterum Therapeutics plc annual Depreciation for 2022 was $84K, a 78.5% decline from 2021.
- Iterum Therapeutics plc annual Depreciation for 2021 was $391K, a 143% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)